Ribonexus: Overcoming resistance to cancer treatments
… can fight cancer treatment resistance. This research, which was developed at Université Paris-Saclay, is the purpose … it was renamed Ribonexus in November 2021. In February 2022, it received €1.5 million in funding from the BPI. … in patients with cancer. Testing new molecules In order to do this, the Ribonexus team is looking for the best …
Published on: